AI assistant
Sending…
Vistin Pharma — Director's Dealing 2023
May 31, 2023
3782_dirs_2023-05-31_e1f3b7bf-4dfb-4832-8cbd-38ff35cbaeae.html
Director's Dealing
Open in viewerOpens in your device viewer
Vistin Pharma ASA: Mandatory notification of trade
Vistin Pharma ASA: Mandatory notification of trade
Magnus Tolleshaug, Chief Commercial Officer in Vistin Pharma ASA, and a primary
insider, has on 31(st) of May 2023 purchased 15.000 shares in Vistin Pharma ASA
at an average price of NOK 24,01 per share. Following this purchase Magnus
Tolleshaug holds 35.000 shares in Vistin Pharma ASA.
More from Vistin Pharma
Notice of Dividend Amount
2026
May 22
AGM Information
2026
May 20
Report Publication Announcement
2026
May 20
Declaration of Voting Results & Voting Rights Announcements
2026
May 20
Proxy Solicitation & Information Statement
2026
Apr 28
Remuneration Information
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 28
Annual Report
2026
Apr 28
Annual Report
2026
Apr 28
AGM Information
2026
Apr 28